v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash Flows From Operating Activities:    
Net loss $ (4,661,206) $ (4,704,147)
Adjustments to reconcile net loss to cash used in operating activities    
Change in fair value of warrant liability (858)
Change in fair value of investment option liability (1,707)
Loss on write-off of deferred offering costs 19,597
Stock based compensation 213,787 400,108
Amortization of intangibles 42,180
Depreciation expense 74,066 78,824
Change in operating assets and liabilities:    
Due to related parties (73,125) (133,016)
Prepaid expenses and other current assets (276,132) 48,192
Accounts payable, accrued expenses and other current liabilities 1,635 (11,300)
Net cash used in operating activities (4,701,378) (4,281,724)
Cash Flows From Financing Activities:    
Proceeds from sale of Common Stock and warrants, net of offering costs 5,552,765 4,244,467
Proceeds from Common Stock sold for cash pursuant to the ATM Agreement, net of offering costs 1,291,038 578,499
Payment of deferred offering costs (18,838)
Proceeds from exercise of warrants 1,523,242 75,044
Net cash provided by financing activities 8,348,207 4,898,010
Effect of foreign exchange rate on changes on cash (28,024) (7,496)
Net increase in cash 3,618,805 608,790
Cash at beginning of period 4,677,491 2,241,026
Cash at end of period 8,296,296 2,849,816
Supplemental disclosure of cash flow transactions:    
Cash paid for interest
Income taxes paid
Non-cash financing and investing activities:    
Non-cash issuance of round-up shares 874
Non-cash issuance of RSA vested shares 146
Issuance of Placement Agent Warrants as offering costs 286,000
Deferred offering costs not paid 26,257
Offering costs accrued not paid $ 22,995